Back to top
more

Molina Healthcare (MOH)

(Real Time Quote from BATS)

$153.76 USD

153.76
994,374

-4.39 (-2.78%)

Updated Aug 5, 2025 02:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value F Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 1% (244 out of 246)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Will Molina (MOH) Beat Estimates Again in Its Next Earnings Report?

by Zacks Equity Research

Molina (MOH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Equity Research

Weakness Seen in Select Medical Holdings (SEM) Estimates: Should You Stay Away?

by Zacks Equity Research

Select Medical Holdings (SEM) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.

Zacks Equity Research

Has Molina Healthcare (MOH) Outpaced Other Medical Stocks This Year?

by Zacks Equity Research

Is (MOH) Outperforming Other Medical Stocks This Year?

Zacks Equity Research

DXC Technology to Buy Luxoft to Expand Digital Business

by Zacks Equity Research

DXC Technology (DXC) aims to expedite the digital transformation journey across its clients and strengthen Digital Solutions business with the acquisition of Luxoft.

Zacks Equity Research

Molina Healthcare (MOH) in Focus: Stock Moves 7.4% Higher

by Zacks Equity Research

Molina Healthcare (MOH) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

Zacks Equity Research

Molina Renews Pact With CVS to Boost PBM Service Platform

by Zacks Equity Research

Molina (MOH) expands deal with CVS Caremark for Pharmacy Benefit Management services.

Zacks Equity Research

Ensign Group's (ENSG) Buyout to Expand Business in Utah

by Zacks Equity Research

Ensign Group (ENSG) acquires the real estate and operations of Bella Terra Cedar City to bolster its growth profile.

Zacks Equity Research

Anthem or Humana: Which HMO Stock is a Better Buy for 2019?

by Zacks Equity Research

The health insurance industry is poised for growth despite some policy disturbances; here we analyze which stock Anthem or Humana would provide greater returns in 2019.

Zacks Equity Research

Should Value Investors Buy Molina (MOH) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Tenet (THC) Signs Deal to Provide Services to Cigna Members

by Zacks Equity Research

Tenet (THC) enters new agreements to provide in-network access to Cigna members

Zacks Equity Research

Which Stock to Emulate HCA Healthcare (HCA) Success in 2019?

by Zacks Equity Research

While HCA Healthcare (HCA) has been a runaway winner this year, other companies by virtue of strong operating fundamentals are poised for growth in 2019.

Zacks Equity Research

The Zacks Analyst Blog Highlights: Computer Programs and Systems, BioTelemetry, HMS, Amedisys and Molina Healthcare

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Computer Programs and Systems, BioTelemetry, HMS, Amedisys and Molina Healthcare

Swarup Gupta headshot

5 Great Healthcare Stocks to Buy for 2019

by Swarup Gupta

Rapid innovation, major advances and an ageing population have managed to sustain the popularity of healthcare stocks.

Zacks Equity Research

Centene Unit Collaborates With RxAdvance for New PBM Platform

by Zacks Equity Research

Centene's (CNC) Mississippi unit partners RxAdvance for establishing a transformative pharmacy benefit management model.

Sapna Bagaria headshot

4 HMOs Likely to Cruise Ahead of Industry in 2019

by Sapna Bagaria

Players in the HMO industry should gain from aging population, expanding government business, technological investment and industry consolidation

Zacks Equity Research

Has Molina Healthcare (MOH) Outpaced Other Medical Stocks This Year?

by Zacks Equity Research

Is (MOH) Outperforming Other Medical Stocks This Year?

Nalak Das headshot

U.S. Dollar Hits 19-Month High: 5 Top Domestic Picks

by Nalak Das

Weaker-than-expected economic data from China and the European Union and concerns about emerging markets' ability to service their external debt have raised the possibility of global slowdown.

Zacks Equity Research

Can a Divided Congress Boost Healthcare Stocks? 4 Picks

by Zacks Equity Research

A divided Congress ensures Obamacare stays in place.

Zacks Equity Research

Moody's Downgrades Acadia's (ACHC) Outlook, Affirms Ratings

by Zacks Equity Research

Acadia Healthcare (ACHC) receives rating actions from Moody's. Outlook down to negative from stable.

Zacks Equity Research

Molina (MOH) Gains As Market Dips: What You Should Know

by Zacks Equity Research

Molina (MOH) closed at $140.01 in the latest trading session, marking a +1.12% move from the prior day.

Zacks Equity Research

Increased Earnings Estimates Seen for Molina Healthcare (MOH): Can It Move Higher?

by Zacks Equity Research

Molina Healthcare (MOH) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors.

Sapna Bagaria headshot

HMO Industry Surges Almost 4 Times S&P 500: 4 Picks

by Sapna Bagaria

Health insurers gains on strong industry and operating conditions, the same should continue in 2019.

Zacks Equity Research

Molina (MOH) Up 10.7% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Molina (MOH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Humana to Gain from Share Buyback, Raise Membership Outlook

by Zacks Equity Research

Humana (HUM) announces accelerated share buyback and gears up for increased Medicare Advantage membership.

Zacks Equity Research

Is Molina Healthcare (MOH) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Is (MOH) Outperforming Other Medical Stocks This Year?